{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:17:52Z","timestamp":1793459872460,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"SHOWA Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Recent studies have reported that high mean corpuscular volume (MCV) may be associated with mortality in chronic kidney disease patients. A high MCV is caused by erythropoietin-stimulating agent (ESA). Most patients with protein-energy wasting (PEW) have functional iron deficiency (FID) and need a high ESA dose. FID is associated with low total iron binding capacity (TIBC), which is a marker of iron status, malnutrition, and inflammation, and it may be a predictor of muscle loss. The relationships between high MCV and iron status markers in patients on hemodialysis (HD) are not well known. The aim of this study was to assess the relationships between high MCV and iron status markers in a cross-sectional and longitudinal study considering nutritional status, inflammation, muscle mass, and hydration status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A prospective cohort of 39 HD patients was examined for 12\u00a0months. The relationships between MCV and iron status markers (TIBC, ferritin, hepcidin-25, iron) were examined using multivariate linear regression analysis and multivariate repeated measures analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At baseline, a high MCV (\u2265\u2009100 fL) was significantly related to low TIBC and low muscle mass. Multiple regression analysis showed that MCV was associated with low TIBC. On multivariate repeated measures analysis, MCV was associated with a sustained low TIBC, and proportion of PEW and ERI were associated with a sustained high MCV.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>High MCV was associated with low TIBC. Furthermore, a sustained high MCV suggested ESA hypo-responsiveness and tendency to iron use disorder and may be a useful marker of PEW.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10157-026-02887-w","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:21:34Z","timestamp":1780392094000},"page":"1350-1358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationships of high mean corpuscular volume, low total iron binding capacity and protein-energy wasting in patients on maintenance hemodialysis"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2668-8443","authenticated-orcid":false,"given":"Misa","family":"Ikeda-Taniguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Hirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2887_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-12-19","volume":"12","author":"KK Tennankore","year":"2011","unstructured":"Tennankore KK, Soroka SD, West KA, Kiberd BA. Macrocytosis may be associated with mortality in chronic hemodialysis patients: a prospective study. BMC Nephrol. 2011;12:19.","journal-title":"BMC Nephrol"},{"issue":"2","key":"2887_CR2","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2215\/CJN.00970116","volume":"12","author":"Y-P Hsieh","year":"2017","unstructured":"Hsieh Y-P, Chang C-C, Kor C-T, Yang Y, Wen Y-K, Chiu P-F. Mean corpuscular volume and mortality in patients with CKD. Clin J Am Soc Nephrol. 2017;12(2):237\u201344.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2887_CR3","first-page":"368","volume":"21","author":"R Afshar","year":"2010","unstructured":"Afshar R, Sanavi S, Salimi J, Ahmadzadeh M. Hematological profile of chronic kidney disease (CKD) patients in Iran, in pre dialysis stages and after initiation of hemodialysis. Saudi J Kidney Dis Transpl. 2010;21(2):368\u201371.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"2887_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72765-2","volume":"10","author":"H Honda","year":"2020","unstructured":"Honda H, Kimachi M, Kurita N, Joki N, Nangaku M. Low rather than high mean corpuscular volume is associated with mortality in Japanese patients under hemodialysis. Sci Rep. 2020;10(1):15663.","journal-title":"Sci Rep"},{"key":"2887_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2310\/6650.2001.34044","volume":"49","author":"VE Pollak","year":"2001","unstructured":"Pollak VE, Lorch JA, Means RT Jr. Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients. J Investig Med. 2001;49:173\u201383.","journal-title":"J Investig Med"},{"key":"2887_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ki.5002585","volume":"73","author":"D Fouque","year":"2008","unstructured":"Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Cuppari L, Franch H, et al. A proposed nomenclature and diagnostic criteria for protein\u2013energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391\u20138.","journal-title":"Kidney Int"},{"issue":"6","key":"2887_CR7","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/ki.2013.147","volume":"84","author":"TA Ikizler","year":"2013","unstructured":"Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096\u2013107.","journal-title":"Kidney Int"},{"issue":"2","key":"2887_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1053\/ajkd.1998.v31.pm9469497","volume":"31","author":"K Kalantar-Zadeh","year":"1998","unstructured":"Kalantar-Zadeh K, Kleiner M, Dunne E, Ahern K, Nelson M, Koslowe R, et al. Total Iron-binding capacity estimated transferrin correlates with the nutritional subjective global assessment in hemodialysis patients. Am J Kidney Dis. 1998;31(2):263\u201372.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2887_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/nu11051123","volume":"11","author":"G Tarantino","year":"2019","unstructured":"Tarantino G, Vinciguerra M, Ragosta A, Citro V, Conforti P, Salvati G, et al. Do transferrin levels predict haemodialysis adequacy in patients with end-stage renal disease? Nutrients. 2019;11(5):1123.","journal-title":"Nutrients"},{"issue":"6","key":"2887_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10157-022-02193-1","volume":"26","author":"M Ikeda-Taniguchi","year":"2022","unstructured":"Ikeda-Taniguchi M, Takahashi K, Shishido K, Honda H. Total iron binding capacity is a predictor for muscle loss in maintenance hemodialysis patients. Clin Exp Nephrol. 2022;26(6):583\u201392.","journal-title":"Clin Exp Nephrol"},{"issue":"4","key":"2887_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1590\/2175-8239-jbn-2018-0092","volume":"41","author":"J Carvalho Romagnolli Plastina","year":"2019","unstructured":"Carvalho Romagnolli Plastina J, Obara VY, Sabbatini Barbosa D, Morimoto HK, Maria Vissoci Reiche E, Graciano A, et al. Functional iron deficiency in patients on hemodialysis: prevalence, nutritional assessment, and biomarkers of oxidative stress and inflammation. J Bras Nefrol. 2019;41(4):472\u201380.","journal-title":"J Bras Nefrol."},{"issue":"8","key":"2887_CR12","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.2215\/CJN.02190309","volume":"4","author":"B Young","year":"2009","unstructured":"Young B, Zaritsky J. Hepcidin for clinicians. Clin J Am Soc Nephrol. 2009;4(8):1384\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2887_CR13","unstructured":"2015 JSDT Guideline for renal anemia in chronic kidney disease."},{"issue":"5","key":"2887_CR14","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","volume":"66","author":"KDOQI clinical practice guideline for hemodialysis adequacy","year":"2015","unstructured":"KDOQI clinical practice guideline for hemodialysis adequacy. 2015 update. Am J Kidney Dis. 2015;66(5):884\u2013930.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"2887_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1080\/0886022X.2021.1922442","volume":"43","author":"R P\u00e9rez-Morales","year":"2021","unstructured":"P\u00e9rez-Morales R, Donate-Correa J, Mart\u00edn-N\u00fa\u00f1ez E, P\u00e9rez-Delgado N, Ferri C, Lopez-Montes A, et al. Extracellular water\/total body water ratio as predictor of mortality in hemodialysis patients. Ren Fail. 2021;43(1):821\u20139.","journal-title":"Ren Fail"},{"key":"2887_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/ndt\/16.1.91","volume":"16","author":"SW Lee","year":"2001","unstructured":"Lee SW, Song JH, Kim GA, Kim MJ. Assessment of total body water from anthropometry based equations using bioelectrical impedance as reference in Korean adult control and haemodialysis subjects. Nephrol Dial Transplant. 2001;16:91\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"2887_CR17","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1681\/ASN.V8121906","volume":"8","author":"W Arkouche","year":"1997","unstructured":"Arkouche W, Fouque D, Pachiaudi C, Normand S, Laville M, Delawari E, et al. Total body water and body composition in chronic peritoneal dialysis patients. J Am Soc Nephrol. 1997;8:1906\u201314.","journal-title":"J Am Soc Nephrol"},{"key":"2887_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-15-189","volume":"15","author":"R Tai","year":"2014","unstructured":"Tai R, Ohashi Y, Mizuiri S, Aikawa A, Sakai K. Association between ratio of measured extracellular volume to expected body fluid volume and renal outcomes in patients with chronic kidney disease: a retrospective single-center cohort study. BMC Nephrol. 2014;15:189.","journal-title":"BMC Nephrol"},{"issue":"1","key":"2887_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1681\/ASN.0000000000000240","volume":"35","author":"C Delgado","year":"2024","unstructured":"Delgado C, Powe NR, Chertow GM, Grimes B, Johansen KL. Muscle mass and serum creatinine concentration by race and ethnicity among hemodialysis patients. J Am Soc Nephrol. 2024;35(1):66\u201373.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2887_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000523947","volume":"53","author":"DA Goodkin","year":"2022","unstructured":"Goodkin DA, Zhao J, Cases A, Nangaku M, Karaboyas A. Resistance to erythropoiesis-stimulating agents among patients on hemodialysis is typically transient. Am J Nephrol. 2022;53(5):333\u201342.","journal-title":"Am J Nephrol"},{"issue":"Suppl 5","key":"2887_CR21","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1016\/j.htct.2024.04.125","volume":"46","author":"S Bakr","year":"2024","unstructured":"Bakr S, Salem KM, Rashed AM, Tantawy MEA, Elsary AY, Shamardl HA, et al. Evaluation of hepcidin-25\/erythroferrone ratio as a potential biomarker for iron utility and erythropoiesis responsiveness to erythropoiesis-stimulating therapy in comparison to immature erythrocyte\/reticulocyte parameters in hemodialysis patients. Hematol Transfus Cell Ther. 2024;46(Suppl 5):S214\u201322.","journal-title":"Hematol Transfus Cell Ther."},{"issue":"3","key":"2887_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.2021014326","volume":"139","author":"JL Babitt","year":"2022","unstructured":"Babitt JL. Erythroferrone in iron regulation and beyond. Blood. 2022;139(3):319\u201321.","journal-title":"Blood."},{"issue":"3","key":"2887_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/ki.2011.141","volume":"80","author":"DW Coyne","year":"2011","unstructured":"Coyne DW. Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney Int. 2011;80(3):240\u20134.","journal-title":"Kidney Int"},{"issue":"1-2","key":"2887_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000504240","volume":"49","author":"RM Hanna","year":"2020","unstructured":"Hanna RM, Ghobry L, Wassef O, Rhee CM, Kalantar-Zadeh K. A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif. 2020;49(1\u20132):202\u201311.","journal-title":"Blood Purif"},{"issue":"7","key":"2887_CR25","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1093\/ndt\/gfs368","volume":"28","author":"M Rattanasompattikul","year":"2013","unstructured":"Rattanasompattikul M, Molnar MZ, Zaritsky JJ, Hatamizadeh P, Jing J, Norris KC, et al. Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant. 2013;28(7):1936\u201345.","journal-title":"Nephrol Dial Transplant"},{"key":"2887_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/IJNRD.S239151","volume":"13","author":"EJF Santos","year":"2020","unstructured":"Santos EJF, Dias RSC, Lima JFB, Filho NS, Santos AMD. Erythropoietin resistance in patients with chronic kidney disease: current perspectives. Int J Nephrol Renovasc Dis. 2020;13:231\u20137.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"12","key":"2887_CR27","doi-asserted-by":"publisher","first-page":"101306","DOI":"10.1016\/j.xcrm.2023.101306","volume":"4","author":"E Mina","year":"2023","unstructured":"Mina E, Wyart E, Sartori R, Angelino E, Ivan Z, Rausch V, et al. FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy. Cell Rep Med. 2023;4(12):101306.","journal-title":"Cell Rep Med."},{"key":"2887_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000191470","volume":"29","author":"R Bross","year":"2009","unstructured":"Bross R, Zitterkoph J, Pithia J, Benner D, Rambod M, Kovesdy C, et al. Association of serum total iron-binding capacity and its changes over time with nutritional and clinical outcomes in hemodialysis patients. Am J Nephrol. 2009;29:571\u201381.","journal-title":"Am J Nephrol"},{"issue":"2","key":"2887_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2220\/biomedres.8.133","volume":"8","author":"R Matsuda","year":"1987","unstructured":"Matsuda R. Regenerating skeletal muscle contains transferrin and a transferrin-dependent growth factor. Biomed Res. 1987;8(2):133\u20136.","journal-title":"Biomed Res"},{"issue":"1S","key":"2887_CR30","first-page":"S1","volume":"109","author":"KDIGO","year":"2026","unstructured":"KDIGO. 2026 clinical practice guideline for the management of anemia in chronic kidney disease (CKD). Kidney Int. 2026;109(1S):S1\u201399.","journal-title":"Kidney Int"},{"key":"2887_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.697523","volume":"8","author":"A Sabatino","year":"2021","unstructured":"Sabatino A, Broers NJH, van der Sande FM, Hemmelder MH, Fiaccadori E, Kooman JP. Estimation of muscle mass in the integrated assessment of patients on hemodialysis. Front Nutr. 2021;8:697523.","journal-title":"Front Nutr"},{"issue":"1","key":"2887_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.jrn.2011.12.006","volume":"23","author":"Y Ohashi","year":"2013","unstructured":"Ohashi Y, Otani T, Tai R, Tanaka Y, Sakai K, Aikawa A. Assessment of body composition using dry mass index and ratio of total body water to estimated volume based on bioelectrical impedance analysis in chronic kidney disease patients. J Ren Nutr. 2013;23(1):28\u201336.","journal-title":"J Ren Nutr"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02887-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02887-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:46:40Z","timestamp":1787723200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02887-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2887"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02887-w","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.I-T., K.H., and K.S. have declared no competing interests. H.H. is a scientific advisor for Astellas Pharma, Bayer Yakuhin, Kyowa Kirin, Mitsubishi Tanabe Pharma, and Torii Pharmaceutical and has received research funds from Chugai Pharmaceutical, Kyowa Kirin, Otsuka Pharmaceutical, and Torii Pharmaceutical, as well as lecture fees from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Mitsubishi Tanabe Pharma, and Torii Pharmaceutical outside the submitted work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complied with the Declaration of Helsinki. Ethical approval was obtained from the ethics committee of Showa Medical University (1259). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Research involving human participants","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients before enrollment.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}